Michael Slade, MD MSCI

2nd Year Fellow, Co-Chief Fellow

Hometown: Ringgold, Georgia
Medical School: Washington University in Saint Louis
Residency: Washington University in St. Louis/Barnes-Jewish Hospital
Research/Academic Interests: Hematopoietic cell transplantation, Myeloid malignancies
Bio: I moved here eight years ago for medical school and fell in love with the Saint Louis experience. The combination of a world-class medical center and an extremely livable city is almost impossible to beat. In my free time, I enjoy watching Georgia football, playing ultimate frisbee and walking my dog in Tower Grove Park with my wife.

Selected Publications/Abstracts

  • Rashid N, Slade M, Abboud R, Gao F, DiPersio JF, Westervelt P, Uy G, Stockerl-Goldstein K, Romee R, Schroeder MA. The Effect of Donor Type on Outcomes in Adults With Acute Myeloid Leukemia After Reduced Intensity Hematopoietic Peripheral Blood Cell Transplant. Transpl Int 2020 May 29; [Epub ahead of print]
  • Rimando J, Slade M, DiPersio JF, Westervelt P, Gao F, Liu C, Romee R. The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-Versus-Host Disparity Is Associated With Increased Acute Graft-Versus-Host Disease in Haploidentical Transplantation With Post-Transplantation Cyclophosphamide. Biol Blood Marrow Transplant 2020 Jan;26(1):123-131
  • Heberton MM, Tripathi S, Slade M, Trinkaus K, Romee R, Anadkat M. Cutaneous Graft-Versus-Host Disease Incidence Is Similar in Haploidentical and Matched Unrelated Hematopoietic Transplant Recipients: A Retrospective Cohort Study. J Am Acad Dermatol 2019 Nov 2; [Epub ahead of print]
  • Rimando J, Slade M, DiPersio JF, Westervelt P, Gao F, Liu C, Romee R. HLA Epitope Mismatch in Haploidentical Transplantation Is Associated With Decreased Relapse and Delayed Engraftment. Blood Adv 2018 Dec 26;2(24):3590-3601
  • Huselton E, Slade M, Trinkaus KM, DiPersio JF, Westervelt P, Romee R. Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2018 Oct;24(10):2047-2055
  • Fakhri B, Fiala M, Slade M, Westervelt P, Ghobadi A. Donor-Derived Smoldering Multiple Myeloma Following a Hematopoietic Cell Transplantation for AML. Case Rep Hematol 2017;2017:3728429
  • Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Schroeder MA, Gao F, Romee R. Donor-Lymphocyte Infusion Following Haploidentical Hematopoietic Cell Transplantation With Peripheral Blood Stem Cell Grafts and PTCy. Bone Marrow Transplant 2017 Dec;52(12):1623-1628
  • Slade M, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Romee R. Haploidentical Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults With Acute Myeloid Leukemia or Myelodysplastic Syndrome. Biol Blood Marrow Transplant 2017 Oct;23(10):1736-1743
  • Zou J, Romee R, Slade M, Phelan D, Keller J, Mohanakumar T, Grossman BJ. Untreated Donor Specific Antibodies Against HLA Are Associated With Poor Outcomes in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplant 2017 Jun;52(6):898-901
  • Lin CJ, Vader JM, Slade M, DiPersio JF, Westervelt P, Romee R. Cardiomyopathy in Patients After Posttransplant Cyclophosphamide-Based Hematopoietic Cell Transplantation. Cancer 2017 May 15;123(10):1800-1809
  • Huselton E, Slade M, DiPersio JF, Westervelt P, Vij R, Uy GL, Fehniger TA, Abboud CN, Gao F, Schroeder MA, Romee R. Single Institution Experience With G-CSF Mobilized T-Cell Replete Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplant 2017 May;52(5):769-771
  • Zou J, Duffy B, Slade M, Young AL, Steward N, Hachem R, Mohanakumar T. Rapid Detection of Donor Cell Free DNA in Lung Transplant Recipients With Rejections Using Donor-Recipient HLA Mismatch. Hum Immunol 2017 Apr;78(4):342-349
  • How J, Slade M, Vu K, DiPersio JF, Westervelt P, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Romee R. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation From Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia. Biol Blood Marrow Transplant 2017 Apr;23(4):648-653
  • Slade M, Goldsmith S, Romee R, DiPersio JF, Dubberke ER, Westervelt P, Uy GL, Lawrence SJ. Epidemiology of Infections Following Haploidentical Peripheral Blood Hematopoietic Cell Transplantation. Transpl Infect Dis 2017 Feb;19(1)
  • Srour SA, Milton DR, Bashey A, Karduss-Urueta A, Al Malki MM, Romee R, Solomon S, Nademanee A, Brown S, Slade M, Perez R, Rondon G, Forman SJ, Champlin RE, Kebriaei P, Ciurea SO. Haploidentical Transplantation With Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant 2017 Feb;23(2):318-324
  • Fiala MA, Slade M, Wang S, Park S, DiPersio J, Stockerl-Goldstein K. The Impact of Diabetes Mellitus and Other Comorbidities on Hematopoietic Stem Cell Collection and Hematologic Recovery Post-Transplantation. Leuk Lymphoma 2017 Jan;58(1):241-243
  • Slade M, Fakhri B, Savani BN, Romee R. Halfway There: The Past, Present and Future of Haploidentical Transplantation. Bone Marrow Transplant 2017 Jan;52(1):1-6
  • Rashidi A, Slade M, DiPersio JF, Westervelt P, Vij R, Romee R. Post-Transplant High-Dose Cyclophosphamide After HLA-Matched Vs Haploidentical Hematopoietic Cell Transplantation for AML. Bone Marrow Transplant 2016 Dec;51(12):1561-1564
  • Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Dubberke ER, Trinkaus K, Romee R. Cytomegalovirus Viremia, Disease, and Impact on Relapse in T-Cell Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide. Haematologica 2016 Nov;101(11):e465-e468
  • Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R. Severe Cytokine-Release Syndrome After T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated With Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated. Biol Blood Marrow Transplant 2016 Oct;22(10):1851-1860
  • Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE. Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation.
    Transfusion 2016 Sep;56(9):2331-5